FADDA, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 209.857
NA - Nord America 14.802
AS - Asia 6.383
SA - Sud America 1.014
Continente sconosciuto - Info sul continente non disponibili 587
AF - Africa 185
OC - Oceania 19
Totale 232.847
Nazione #
IT - Italia 201.108
US - Stati Uniti d'America 14.509
NL - Olanda 5.120
SG - Singapore 2.488
CN - Cina 2.152
UA - Ucraina 825
SE - Svezia 811
BR - Brasile 799
DE - Germania 507
VN - Vietnam 502
FI - Finlandia 443
GB - Regno Unito 410
FR - Francia 297
IN - India 211
HK - Hong Kong 197
CA - Canada 152
KR - Corea 148
BD - Bangladesh 117
TR - Turchia 89
IQ - Iraq 70
AR - Argentina 69
MX - Messico 69
JP - Giappone 56
ES - Italia 51
RU - Federazione Russa 50
PL - Polonia 48
SA - Arabia Saudita 41
EC - Ecuador 40
ZA - Sudafrica 38
PK - Pakistan 36
MA - Marocco 34
UZ - Uzbekistan 32
AT - Austria 29
VE - Venezuela 29
BE - Belgio 28
ID - Indonesia 27
PH - Filippine 27
CO - Colombia 26
CZ - Repubblica Ceca 22
NP - Nepal 22
JO - Giordania 21
KE - Kenya 21
IE - Irlanda 20
IR - Iran 18
AE - Emirati Arabi Uniti 16
AU - Australia 16
EG - Egitto 16
CL - Cile 15
JM - Giamaica 15
MY - Malesia 15
ET - Etiopia 14
IL - Israele 14
BO - Bolivia 12
EU - Europa 12
CH - Svizzera 11
LB - Libano 11
AZ - Azerbaigian 10
CR - Costa Rica 10
DZ - Algeria 10
PA - Panama 10
PY - Paraguay 10
TN - Tunisia 10
GR - Grecia 9
RS - Serbia 9
DO - Repubblica Dominicana 8
LT - Lituania 8
HU - Ungheria 7
OM - Oman 7
PT - Portogallo 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
GE - Georgia 6
HR - Croazia 6
KZ - Kazakistan 6
NG - Nigeria 6
SN - Senegal 6
UY - Uruguay 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
PE - Perù 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
KG - Kirghizistan 4
NI - Nicaragua 4
PR - Porto Rico 4
RO - Romania 4
SC - Seychelles 4
BA - Bosnia-Erzegovina 3
KH - Cambogia 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
AL - Albania 2
BH - Bahrain 2
BS - Bahamas 2
Totale 232.221
Città #
Cagliari 195.517
Amsterdam 5.054
Uta 4.633
Ashburn 1.300
Singapore 1.223
Fairfield 1.057
Chandler 870
Woodbridge 841
San Jose 811
Dallas 720
Ann Arbor 683
Houston 614
Boardman 553
Jacksonville 448
Seattle 448
Nyköping 443
Wilmington 410
Cambridge 357
Beijing 355
Council Bluffs 324
Los Angeles 309
Dearborn 290
Helsinki 269
New York 225
Hefei 193
Santa Clara 186
Hong Kong 179
Shanghai 176
Nanjing 167
Lauterbourg 161
The Dalles 154
Boston 152
Seoul 138
Ho Chi Minh City 130
Hanoi 116
Milan 102
Buffalo 87
Munich 80
Columbus 75
Orem 72
Rome 67
San Diego 67
São Paulo 67
Atlanta 65
Shenyang 64
Guangzhou 62
London 62
Denver 61
Dong Ket 61
Chennai 56
Frankfurt am Main 54
Redwood City 53
Toronto 52
Chicago 51
Tianjin 48
San Francisco 47
Brooklyn 46
Tokyo 45
Washington 45
Nanchang 43
Redondo Beach 42
Mountain View 41
Sassari 39
Montreal 37
Warsaw 37
Verona 36
Jiaxing 34
Phoenix 33
Turku 33
Manchester 32
Hebei 31
Kocaeli 30
Tashkent 29
Changsha 28
Norwalk 28
Pune 28
Baghdad 27
Madrid 27
Paris 27
Brussels 26
Nuremberg 26
Wuhan 25
Orange 22
Stockholm 22
Mumbai 21
Poplar 21
Rio de Janeiro 21
Belo Horizonte 20
Brasília 20
Da Nang 20
Kunming 20
Las Vegas 20
Johannesburg 19
Mexico City 19
Nairobi 19
Ningbo 19
Amman 18
Dhaka 18
Dublin 18
Jinan 18
Totale 222.089
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.679
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 5.147
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function 4.493
Maternal immune activation disrupts dopamine system in the offspring 4.164
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.918
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.388
BEHAVIORAL EFFECTS OF ACUTE ADMINISTRATION OF THE PPAR-α AGONIST PALMITOYLETHANOLAMIDE IN RATS 3.380
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.364
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.349
Emotional profile of female rats showing binge eating behavior 3.264
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones. 3.240
Sex differences in addictive disorders 3.189
Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats 3.175
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.104
Acute administration of palmitoylethanolamide: behavioural studies 2.988
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.980
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.968
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.910
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.886
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings 2.861
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.856
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.830
Antidepressant-like effect of clofibrate: a synthetic PPAR-a agonist 2.782
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.724
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.605
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.603
The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission 2.592
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.518
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.484
Piano di uguaglianza di genere dell’Università degli Studi di Cagliari 2.457
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.403
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.398
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 2.391
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.365
Brain activity of anandamide: a rewarding bliss? 2.283
Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview 2.278
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.237
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.236
Increased cannabinoid intravenous self-administration in the olfactory bulbectomy rats model of depression 2.218
Methoxetamine affects brain processing involved in emotional response in rats 2.192
Animal Models of Eating Disorders 2.171
Analysis of opioid-seeking reinstatement in the rat 2.145
The GABA(B) receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats 2.106
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.028
Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo (3.2.1) octanes 1.986
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.962
null 1.948
Chronic Blockade of CB1 Receptors Reverses Startle Gating Deficits and Associated Neurochemical Alterations in Isolation Reared Rats. 1.902
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.891
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.873
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.771
Sex differences in the self-administration of cannabinoids and other drugs of abuse 1.750
THC exposure during adolescence increases cannabinoid and heroin intake in female rats more than in males 1.729
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.688
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats 1.667
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.644
null 1.579
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.515
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.499
Effects of modulation of endocannabinoid system on fat intake under a limited-access protocol of binge eating in female rats 1.464
The endocannabinoid system and nondrug rewarding behaviours 1.462
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.459
Hippocampal theta activity is modulated by cannabinoid type1receptor in rats 1.419
Drug and cue induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones 1.405
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.374
Neurobiological mechanisms of cannabinoid addiction 1.300
Cannabinoids and their therapeutic applications in mental disorders 1.284
Differential effects of THC-or CBD-rich cannabis extracts on working memory in rats 1.279
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.270
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats 1.183
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.167
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.153
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.139
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.083
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 1.068
Cannabinoid-opioid interaction in relapse to drug-seeking 1.066
Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone 1.063
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.040
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.036
Endocannabinoid system and opioid addiction: behavioural aspects 1.023
Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs 1.019
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 967
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives 961
Analysis of opioid-seeking behavior through the intravenous self-administration reinstatement model in rats 959
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 949
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 949
Reduction of Corticostriatal Glutamatergic Fibers in Basic Fibroblast Growth Factor Deficient Mice is Associated with Hyperactivity and Enhanced Dopaminergic Transmission 872
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 869
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 825
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. 806
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 784
Treatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil 783
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 780
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 773
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 762
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 745
null 738
SYNTHETIC AND PLANT-DERIVED CANNABINOID RECEPTOR ANTAGONISTS SHOW HYPOPHAGIC PROPERTIES IN FASTED AND NON-FASTED MICE 728
null 711
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 702
Totale 198.172
Categoria #
all - tutte 307.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 307.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.211 0 831 462 1.043 1.262 804 613 627 1.023 1.282 1.239 1.025
2022/202317.564 1.499 2.292 2.442 1.486 1.397 1.700 815 1.319 1.127 1.154 1.575 758
2023/202417.789 903 649 829 1.222 1.746 3.337 2.416 1.109 990 1.311 1.598 1.679
2024/202539.679 8.541 8.982 5.311 4.107 1.965 2.205 3.168 299 514 3.551 438 598
2025/202614.204 1.172 700 1.353 1.220 975 975 2.012 511 2.710 1.421 818 337
2026/20272.295 774 1.521 0 0 0 0 0 0 0 0 0 0
Totale 232.847